Blockade of the enzyme PDE9 prevents degradation of the molecule cyclic GMP, which has been shown to protect against heart failure. The finding indicates that PDE9 inhibition might be a drug target for treating this condition. See Letter p.472
© 2001-2024 Fundación Dialnet · Todos los derechos reservados